Evogene Ltd. (EVGN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evogene Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.354 Welcome to Evergen's second quarter 2026 results conference call. 00:00:05.354 -- 00:00:08.915 All participants are at present in listen-only mode. 00:00:08.915 -- 00:00:14.078 Following management's formal presentation, we will open the question and answer session. 00:00:14.078 -- 00:00:20.000 You may send questions via chat. Please type your name and company before your question. 00:00:20.000 -- 00:00:25.242 As a reminder, this conference is being recorded August 18, 2026. 00:00:25.890 -- 00:00:30.352 Before we begin, I would like to caution that certain statements made during this earning 00:00:30.352 -- 00:00:35.514 conference call by Evergen's management will constitute forward-looking statements 00:00:35.514 -- 00:00:41.217 that relate to future events. This presentation contains forward-looking statements 00:00:41.217 -- 00:00:44.338 relating to future events and Evergen Ltd. 00:00:44.338 -- 00:00:50.083 may from time to time make other statements regarding our outlook or expectations 00:00:50.083 -- 00:00:55.467 for future financial or operating results and or other matters regarding 00:00:55.467 -- 00:01:00.471 or affecting us that are considered forward-looking statements as defined in the 00:01:00.471 -- 00:01:05.455 U.S. Private Securities Litigation Reform Act of 1995, 00:01:05.455 -- 00:01:07.036 the PSLRA, 00:01:07.036 -- 00:01:12.719 and other securities law as amended. Statements that are not statements of historical 00:01:12.719 -- 00:01:16.340 fact may be deemed to be forward-looking statements. 00:01:16.340 -- 00:01:21.461 Such forward-looking statements may be identified by the use of such words as 00:01:21.461 -- 00:01:26.602 believe, accept, anticipate, should, planned, estimated, 00:01:26.602 -- 00:01:30.774...